{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:36:13Z","timestamp":1767173773969,"version":"build-2238731810"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":8262,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1997]]},"DOI":"10.1254\/jjp.60.105","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T00:07:03Z","timestamp":1201133223000},"page":"105-112","source":"Crossref","is-referenced-by-count":15,"title":["Effect of T-0632, a CholecystokininA Receptor Antagonist, on Experimental Acute Pancreatitis"],"prefix":"10.1016","volume":"73","author":[{"given":"Hiroyuki","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Yomota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshirou","family":"Shikano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.60.105_bib1","series-title":"The Pancreas: Biology, Pathobiology, and Disease","first-page":"581","article-title":"Etiology and pathophysiology of acute pancreatitis","author":"Steer","year":"1993"},{"key":"10.1254\/jjp.60.105_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0196-9781(94)90104-X","article-title":"Biological actions of cholecystokinin","volume":"15","author":"Crawley","year":"1994","journal-title":"Peptides"},{"key":"10.1254\/jjp.60.105_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/bjs.1800810805","article-title":"Experimental models of acute pancreatitis","volume":"81","author":"Banerjee","year":"1994","journal-title":"Br J Surg"},{"key":"10.1254\/jjp.60.105_bib4","first-page":"159","article-title":"Experimental animal models of acute pancreatitis.","volume":"15","author":"Lerch","year":"1994","journal-title":"Int J Pancreatol"},{"key":"10.1254\/jjp.60.105_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02788433","article-title":"Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation","volume":"2","author":"Tani","year":"1987","journal-title":"Int J Pancreatol"},{"key":"10.1254\/jjp.60.105_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0016-5085(89)90779-8","article-title":"Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice","volume":"96","author":"Silverman","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1254\/jjp.60.105_bib7","first-page":"1172","article-title":"Loxiglumide protects against experimental pancreatitis","volume":"37","author":"Setnikar","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.60.105_bib8","first-page":"515","article-title":"Cerulein-induced pancreatitis in the ex vivo isolated perfused canine pancreas","volume":"109","author":"Clemens","year":"1991","journal-title":"Surgery"},{"key":"10.1254\/jjp.60.105_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/jsre.1993.1019","article-title":"Increased circulating cholecystokinin in obstruction-induced acute pancreatitis: I. bile duct obstruction with and without pancreatic duct obstruction","volume":"54","author":"Murayama","year":"1993","journal-title":"J Surg Res"},{"key":"10.1254\/jjp.60.105_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00006676-199409000-00015","article-title":"Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusidn in rats","volume":"9","author":"Tomita","year":"1994","journal-title":"Pancreas"},{"key":"10.1254\/jjp.60.105_bib11","first-page":"450","article-title":"Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis","volume":"122","author":"Toriumi","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1254\/jjp.60.105_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0016-5085(91)90601-G","article-title":"Effects of short-term pancreatic duct obstruction in rats","volume":"100","author":"Ohshio","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1254\/jjp.60.105_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(96)00091-X","article-title":"Pharmacological profile of T-0632, a novel potent and selective CCKA-receptor antagonist, in vitro","volume":"304","author":"Taniguchi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.60.105_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00473-6","article-title":"Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo","volume":"312","author":"Taniguchi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.60.105_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1988.tb13849.x","article-title":"Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin","volume":"172","author":"Kawabata","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1254\/jjp.60.105_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.1800760830","article-title":"Three-dimensional morphological study of the pancreatic microvasculature in caerulein-induced experimental pancreatitis","volume":"76","author":"McEntee","year":"1989","journal-title":"Br J Surg"},{"key":"10.1254\/jjp.60.105_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00006676-199005000-00007","article-title":"Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models","volume":"5","author":"Tani","year":"1990","journal-title":"Pancreas"},{"key":"10.1254\/jjp.60.105_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/jsre.1993.1020","article-title":"Increased circulating cholecystokinin in obstruction-induced acute pancreatitis: II. pancreatic duct obstruction with and without bile duct obstruction.","volume":"54","author":"Toriumi","year":"1993","journal-title":"J Surg Res"},{"key":"10.1254\/jjp.60.105_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/BF01536797","article-title":"Fasting prevents acute pancreatitis induced by cerulein in rats","volume":"35","author":"Otsuki","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1254\/jjp.60.105_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI114703","article-title":"Protective action of luminal bile salts in necrotizing acute pancreatitis in mice","volume":"86","author":"Gomez","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1254\/jjp.60.105_bib21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archsurg.1989.01410050064013","article-title":"Cholecystokinin augmentation of \u2019surgical\u2019 pancreatitis: benefits of receptor blockade","volume":"124","author":"Modlin","year":"1989","journal-title":"Arch Surg"},{"key":"10.1254\/jjp.60.105_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000128192","article-title":"Influence of hormonal stimulation by caerulein on acute experimental pancreatitis in the rat","volume":"13","author":"Evander","year":"1981","journal-title":"Eur Surg Res"},{"key":"10.1254\/jjp.60.105_bib23","first-page":"161","article-title":"Influence of gastrointestinal hormones on the course of acute experimental pancreatitis","volume":"29","author":"Evander","year":"1982","journal-title":"Hepatogastroenterology"},{"key":"10.1254\/jjp.60.105_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(89)90780-4","article-title":"Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models","volume":"96","author":"Lankisch","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1254\/jjp.60.105_bib25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0016-5085(89)90912-8","article-title":"Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis","volume":"96","author":"Ohshio","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1254\/jjp.60.105_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF01536770","article-title":"Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats","volume":"35","author":"Otsuki","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1254\/jjp.60.105_bib27","first-page":"1352","article-title":"Pharmacological studies of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate: Effects on experimental pancreatitis","volume":"40","author":"Murakami","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.60.105_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006676-199405000-00007","article-title":"Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini","volume":"9","author":"Akiyama","year":"1994","journal-title":"Pancreas"},{"key":"10.1254\/jjp.60.105_bib29","series-title":"Cholecystokinin Antagonists in Gastroenterology","first-page":"70","article-title":"Characterization of MK-329. In Cholecystokinin Antagonists in Gastroenterology","author":"Berlin","year":"1991"},{"key":"10.1254\/jjp.60.105_bib30","first-page":"87","article-title":"Potential clinical applications of CCKA-receptor antagonists in gastroenterology","volume":"7","author":"D\u2019Amato","year":"1994","journal-title":"Drug News Perspect"},{"key":"10.1254\/jjp.60.105_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2362.1995.tb01551.x","article-title":"CCK-A antagonists: which and how.","volume":"25","author":"D\u2019Amato","year":"1995","journal-title":"Eur J Clin Invest"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819338387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819338387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:24:14Z","timestamp":1630578254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819338387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":31,"aliases":["10.1254\/jjp.73.105"],"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997]]}},"alternative-id":["S0021519819338387"],"URL":"https:\/\/doi.org\/10.1254\/jjp.60.105","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}